DBV Technologies | DBVT - Attività





Attività Cambiamento Data
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Amarin USD 645.76M 25.01M 2026-03
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
DBV Technologies USD 233.72M 123.22M 2025-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Incyte USD 7.34B 381.14M 2026-03
Insmed USD 2.26B 96.18M 2025-12
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Neurocrine Biosciences USD 4.91B 274.7M 2026-03
PTC Therapeutics USD 2.9B 255.07M 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
United Therapeutics USD 6.71B 1.17B 2026-03